Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Altimmune Inc (ALT)

Altimmune Inc (ALT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 209,612
  • Shares Outstanding, K 43,219
  • Annual Sales, $ 4,410 K
  • Annual Income, $ -97,090 K
  • 60-Month Beta 1.45
  • Price/Sales 49.20
  • Price/Cash Flow N/A
  • Price/Book 1.13
Trade ALT with:

Options Overview Details

View History
  • Implied Volatility 80.11% ( -13.32%)
  • Historical Volatility 91.00%
  • IV Percentile 27%
  • IV Rank 14.05%
  • IV High 174.54% on 09/17/21
  • IV Low 64.66% on 10/20/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 46
  • Volume Avg (30-Day) 126
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 15,255
  • Open Int (30-Day) 15,191

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.45
  • Number of Estimates 4
  • High Estimate -0.43
  • Low Estimate -0.48
  • Prior Year -0.40
  • Growth Rate Est. (year over year) -12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.83 +22.85%
on 05/12/22
5.36 -12.22%
on 05/13/22
+0.01 (+0.32%)
since 04/25/22
3-Month
3.83 +22.85%
on 05/12/22
7.70 -38.90%
on 02/28/22
-2.91 (-38.17%)
since 02/25/22
52-Week
3.83 +22.85%
on 05/12/22
19.46 -75.82%
on 06/16/21
-7.10 (-60.13%)
since 05/25/21

Most Recent Stories

More News
Wall Street Analysts See a 426% Upside in Altimmune, Inc. (ALT): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 425.9% in Altimmune, Inc. (ALT). While the effectiveness of this highly sought-after metric is questionable, the...

ALT : 4.62 (-2.12%)
Altimmune to Present Pemvidutide Clinical Data at Upcoming Global NASH Congress May 27, 2022

GAITHERSBURG, Md., May 20, 2022 (GLOBE NEWSWIRE) --  Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr....

ALT : 4.62 (-2.12%)
Altimmune to Present at Upcoming Investor Conferences

GAITHERSBURG, Md., May 16, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that...

ALT : 4.62 (-2.12%)
ALTIMMUNE INC (ALT) Q1 2022 Earnings Call Transcript

ALT earnings call for the period ending March 31, 2022.

ALT : 4.62 (-2.12%)
Altimmune, Inc. (ALT) Reports Q1 Loss, Misses Revenue Estimates

Altimmune, Inc. (ALT) delivered earnings and revenue surprises of 22.81% and 98.45%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ALT : 4.62 (-2.12%)
PTE : 2.22 (-3.90%)
Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Tops Revenue Estimates

Karyopharm Therapeutics (KPTI) delivered earnings and revenue surprises of 15.87% and 37.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?...

KPTI : 5.56 (+0.72%)
ALT : 4.62 (-2.12%)
Altimmune Enters Oversold Territory (ALT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

ALT : 4.62 (-2.12%)
Altimmune Announces Initiation of 48-week Phase 2 MOMENTUM Trial of Pemvidutide in Obesity

The Company also announces completion of enrollment in 12-week, Phase 1b trial of pemvidutide in subjects with non-alcoholic fatty liver disease (NAFLD)...

ALT : 4.62 (-2.12%)
ALTIMMUNE INC (ALT) Q4 2021 Earnings Call Transcript

ALT earnings call for the period ending December 31, 2021.

ALT : 4.62 (-2.12%)
Altimmune, Inc. (ALT) Reports Q4 Loss, Tops Revenue Estimates

Altimmune, Inc. (ALT) delivered earnings and revenue surprises of 23.44% and 2,145.21%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

ALT : 4.62 (-2.12%)
MDWD : 1.7300 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Altimmune, Inc. is a clinical-stage immunotherapeutics company. It focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease. The company's proprietary platform technologies consist of RespirVec and Densigen. Altimmune Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 5.24
2nd Resistance Point 5.04
1st Resistance Point 4.88
Last Price 4.62
1st Support Level 4.52
2nd Support Level 4.32
3rd Support Level 4.16

See More

52-Week High 19.46
Fibonacci 61.8% 13.49
Fibonacci 50% 11.64
Fibonacci 38.2% 9.80
Last Price 4.62
52-Week Low 3.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar